Relating to manufacturer disclosure requirements and liability for experimental drugs and devices.

HB 3455 requires manufacturers of experimental drugs or devices (including those approved for emergency use by the FDA) to provide clear, summary disclosures about potential health risks to purchasers. Purchasers must then give this disclosure directly to end consumers in person, and providers may only sell the product if someone capable of giving informed consent signs the form. Consumers who don’t receive proper disclosure can sue manufacturers for damages, including pain and suffering, punitive damages, and legal fees. The law applies only to cases occurring on or after September 1, 2025.